|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Rockefeller University Press,
0021-9525/2000//333 $5.00
The Journal of Cell Biology, Volume 148, Number 2,
, 2000 333-342
Original Article |
Reciprocal Role of ERK and Nf-
b Pathways in Survival and Activation of Osteoclasts
tanakas-ort{at}h.u-tokyo.ac.jp
To examine the role of mitogen-activated protein kinase and nuclear factor kappa B (NF-
B) pathways on osteoclast survival and activation, we constructed adenovirus vectors carrying various mutants of signaling molecules: dominant negative Ras (RasDN), constitutively active MEK1 (MEKCA), dominant negative I
B kinase 2 (IKKDN), and constitutively active IKK2 (IKKCA). Inhibiting ERK activity by RasDN overexpression rapidly induced the apoptosis of osteoclast-like cells (OCLs) formed in vitro, whereas ERK activation after the introduction of MEKCA remarkably lengthened their survival by preventing spontaneous apoptosis. Neither inhibition nor activation of ERK affected the bone-resorbing activity of OCLs. Inhibition of NF-
B pathway with IKKDN virus suppressed the pit-forming activity of OCLs and NF-
B activation by IKKCA expression upregulated it without affecting their survival. Interleukin 1
(IL-1
) strongly induced ERK activation as well as NF-
B activation. RasDN virus partially inhibited ERK activation, and OCL survival promoted by IL-1
. Inhibiting NF-
B activation by IKKDN virus significantly suppressed the pit-forming activity enhanced by IL-1
. These results indicate that ERK and NF-
B regulate different aspects of osteoclast activation: ERK is responsible for osteoclast survival, whereas NF-
B regulates osteoclast activation for bone resorption.
Key Words: osteoclast adenovirus apoptosis Ras NF-
B
© 2000 The Rockefeller University Press
Abbreviations used in this paper:
-MEM,
-modified minimum essential medium; CSF, colony stimulating factor; EMSA, electrophoretic mobility shift assay; ERK, extracellular signal-regulated kinase; IKK, I
B kinase; IL-1
, interleukin 1
; MAPK, mitogen-activated protein kinase; MEK, MAPK/ERK kinase; MOI, multiplicity of infection; NF-
B, nuclear factor kappa B; OCLs, osteoclast-like cells; TUNEL, Tdt-mediated dUTP dioxigenin nick-end labeling.
|
|